Richard Rumbold

Procurement Lead and trusted advisor to the Executive Committee, shaping enterprise-wide strategy across procurement, supply resilience, sustainability, and long-term cost outlook. Accountable for delivering sustainable cost reduction programmes aligned to EBITDA, cash flow, and investor expectations, while strengthening supplier resilience and ESG performance. Leading the transformation of a global supply base, embedding responsible sourcing, optimising category strategies, and introducing low-cost regions.

Led global procurement transformation across a highly regulated pharmaceutical environment, delivering value through supply assurance, risk management, sustainability, and cost optimisation. Key Contributions: • Developed and executed global procurement strategy aligned to corporate objectives • Embedded supplier risk, compliance, and sustainability frameworks across global operations • Enhanced supply chain resilience, improving visibility of supplier risk and continuity planning • Owned global procurement data, analytics, and system architecture Key Achievements: • Delivered digital source-to-pay transformation, streamlining end-to-end procurement • Reduced supplier base from 12,700 to 4,000, improving efficiency and governance • Introduced supplier segmentation including ESG and risk criteria • Improved working capital through cash flow optimisation initiatives • Established a global Centre of Excellence driving efficiency and compliance

Built the procurement function from the ground up, establishing strategy, operating model, governance, and team to support rapid global growth. Key Contributions: • Developed enterprise-wide procurement strategy aligned to R&D and commercial scale-up • Led integration of sustainability and ESG principles, embedding ethical sourcing and supplier due diligence aligned to the Modern Slavery Act • Implemented procurement policies, governance frameworks, and sourcing standards • Introduced digital tools (spend analytics, CLM, eRFx) to improve visibility and compliance Key Achievements: • Built a high-performing procurement team and operating model • Introduced supplier governance frameworks incorporating ESG, risk, and compliance metrics • Delivered measurable cost savings through structured sourcing and negotiation • Strengthened cross-functional alignment with R&D, Quality, Supply Chain, and Finance

Led end-to-end outsourced supply chain strategy across procurement, manufacturing, and distribution. Key Achievements: • Delivered £2m annual savings through strategic outsourcing • Ensured continuity of clinical and commercial supply, strengthening resilience and contingency planning • Implemented S&OP process to improve demand and supply alignment • Maintained compliance with regulated pharmaceutical supply chain requirements

Led global external manufacturing supply chains across a network of contract suppliers. Key Achievements: • Delivered £40m+ savings over four years • Reduced supply base from 211 to 118 suppliers • Ensured supplier compliance with global regulatory and quality standards • Strengthened risk management and supply continuity across complex supply chains

Led global manufacturing network strategy across 70+ sites. Key Achievements: • Delivered £6m annual P&L benefit through restructuring • Increased network utilisation from 30% to 74% • Led large-scale transformation and capacity optimisation programmes

GlaxoSmithKline & Legacy Companies Progressive leadership roles across global procurement and supply chain. • Managed large-scale direct and indirect spend across multiple categories • Negotiated complex global contracts and supplier agreements • Led procurement for major capital investment programmes • Built and developed high-performing global teams